期刊文献+

脂蛋白脂酶激活剂艾溴利平类似物的合成

Synthesis of Lipoprotein Lipase Activator Ibrolipim Analogs
下载PDF
导出
摘要 合成了两个新型的艾溴利平类似物——N-2-硝基-4-氯苯基-4-[(膦酸二乙酯基)甲基]苯甲酰肼(5,总收率28.1%)和N-2-四氮唑基-4-氯苯基-4-[(膦酸二乙酯基)甲基]苯甲酰胺(7,总收率30.5%)。以对氯甲基苯甲酸为原料,经酯化、水解和酰氯反应制得中间体4-[(膦酸二乙酯基)甲基]苯甲酰氯(4);4与2-硝基-4-氯苯肼盐酸盐反应合成了5。4先与2-氨基-5-氯苯腈反应制得N-2-氰基-4-氯苯基-4-[(膦酸二乙酯基)甲基]苯甲酰胺(6);6再与叠氮化钠反应合成了7。其结构经1H NMR和IR表征。 Two novel Ibrolipim analogs,diethyl 4-[2-(4-chloro-2-nitrophenyl)hydrazinecarbonyl]benzylphosphonate(5) with 28.1% total yield and 4-{[4-chloro-2-(1H-tetrazol-5-yl)phenyl]carbamoyl}benzylphosphonate(7) with 30.5% total yield,were synthesized.The intermediate diethyl 4-(chlorocarbonyl)benzylphosphonate(4) was prepared by esterification,hydrolysis and chlorination reaction from 4-(chloromethyl)benzoic acid.5 was obtained by the reaction of 4 with(4-chloro-2-nitrophenyl)hydrazine hydrochloride.7 was obtained by the reaction of 4 with 2-amino-5-chlorobenzonitrile,and then reaction with sodium azide in toluene.The structures were characterized by 1H NMR and IR.
出处 《合成化学》 CAS CSCD 北大核心 2012年第2期210-213,共4页 Chinese Journal of Synthetic Chemistry
关键词 脂蛋白脂酶激活剂 艾溴利平 类似物 药物合成 lipoprotein lipase activator Ibrolipim analogs drug synthesis
  • 相关文献

参考文献8

  • 1Kusunoki M,Tsutsumi K,Hara T. Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886[J].Metabolism-Clinical and Experimental,2002,(06):792-795.doi:10.1053/meta.2002.32732.
  • 2Nakayama K,Hara T,Kusunoki M. Effect of the lipoprotein lipase activator IBROLIPIM on adriamycin induced nephritic syndrome in rats[J].Metabolism-Clinical and Experimental,2000,(05):588-593.doi:10.1016/S0026-0495(00)80032-3.
  • 3尹卫东,堤一彦,付国香,袁中华,杨保堂.脂蛋白脂酶活化剂NO-1886抑制糖尿病兔动脉粥样硬化的形成[J].中国药理学通报,2001,17(4):417-420. 被引量:5
  • 4尹卫东,杨保堂,张善春,袁中华,易光辉.诱发糖尿病饲料致新西兰兔动脉粥样硬化作用[J].中国动脉硬化杂志,2001,9(2):100-103. 被引量:9
  • 5Hotamisligil G S,Shargill N S,Spiegelman B M. Adipose expression of tumor necrosis factor-α:Direct role in obesity-linked insulin resistance[J].Science,1993,(5091):87-91.doi:10.1126/science.7678183.
  • 6Defronzo R A,Ferrannini E. A multifaceted syndrome responsible for NIDDN,obesity,hypertension,dyslipidemia and atherosclerotic cardiovascular disease[J].Diabetes Care,1991,(03):173-194.doi:10.2337/diacare.14.3.173.
  • 7Hara T,Cameron-Smith D,Cooney G J. The actions of a novel lipoprotein lipase activator,No-1886,in hypertriglyceridemic fructose-fed rats[J].Metabolism-Clinical and Experimental,1998,(02):149-153.doi:10.1016/S0026-0495(98)90211-6.
  • 8Hara T,Kusunoki M,Tsutsumi K. A lipoprotein lipase activator,No-1886,improves endotheliumdependent relaxation of rat aorta associated with aging[J].European Journal of Pharmacology,1998,(01):75-79.doi:10.1016/S0014-2999(98)00230-1.

二级参考文献3

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部